GO
Loading...

Medicine

More

  • HIV case proves false; porn moratorium called off Friday, 29 Aug 2014 | 10:29 AM ET

    LOS ANGELES— The advocacy group for the adult film industry has called for an industrywide production moratorium after a performer tested positive for HIV. The Free Speech Coalition called for the moratorium Thursday.

  • Aug 29- BioCryst Pharmaceuticals Inc said it expects to initiate a study within weeks to test its antiviral in primates for use against Ebola infections. This $2.4 million National Institute of Allergy and Infectious Diseases funding is in addition to the $22 million contract awarded to BioCryst by the agency last September.

  • *AstraZeneca shares up 2 percent. LONDON, Aug 29- Hopes for AstraZeneca's promising cancer drug pipeline were boosted on Friday by news the company had moved its immuno-oncology medicine MEDI-4736 into a mid-stage study in colorectal cancer.

  • CHICAGO, Aug 28- Genetic studies of some of the earliest Ebola cases in Sierra Leone reveal more than 300 genetic changes in the virus as it leapt from person to person, changes that could blunt the effectiveness of diagnostic tests and experimental treatments now in development, researchers said on Thursday.

  • Ebola response roadmap     Thursday, 28 Aug 2014 | 1:52 PM ET

    GlaxoSmithKline is to begin human testing of an experimental Ebola vaccine. CNBC's Meg Tirrell reports the World Health Organization has released a response roadmap with the goal of stopping the spread of Ebola in 6 to 9 months.

  • GENEVA/ LAGOS Aug 28- The Ebola epidemic in West Africa could infect more than 20,000 people, the U.N. health agency said on Thursday, warning that an international effort costing almost half a billion dollars is needed to overcome the outbreak.

  • Aug 28- OncoMed Pharmaceuticals Inc said the U.S. Food and Drug Administration lifted a partial hold on patient enrolments for three trials testing its experimental cancer drug, vantictumab.

  • US to begin safety testing Ebola vaccine next week Thursday, 28 Aug 2014 | 8:43 AM ET

    The National Institutes of Health announced Thursday that it is launching the safety trial on a vaccine developed by the agency's National Institute of Allergy and Infectious Diseases and GlaxoSmithKline.

  • Human trials of Ebola vaccine to start next week Thursday, 28 Aug 2014 | 8:09 AM ET
    Medicins Sans Frontieres health workers at an isolation camp in Liberia during the visit of the UN Ebola systems coordinator, Aug. 23, 2014.

    The trials will start at the NIH in Maryland. A vaccine is "the first step in a long process" to control Ebola, Dr. Anthony Fauci says. NBC reports.

  • WHO says Ebola outbreak could strike 20,000 people Thursday, 28 Aug 2014 | 6:00 AM ET

    GENEVA, Aug 28- The current Ebola outbreak in West Africa could infect more than 20,000 people, the World Health Organisation said on Thursday in a bleak assessment of the deadly disease.

  • LAUNCESTON, Australia, Aug 28- The resource boom is often cast as both villain and hero in Australia, being simultaneously recognized as a major driver of the country's wealth but also as a destroyer of traditional industries.

  • Venezuela battles obesity amid dearth of good food Wednesday, 27 Aug 2014 | 12:13 AM ET

    BOGOTA, Colombia— Venezuela's socialist government is sounding the alarm about growing waistlines in a country where record food shortages are making it harder to put healthy meals on the table, prompting many people to fill up on empty calories.

  • WASHINGTON, Aug 26- A new method for removing allergens from peanuts means help could soon be on the way for the roughly 2.8 million Americans with a potentially life-threatening allergy to the popular food, the U.S. Department of Agriculture said on Tuesday.

  • WASHINGTON, Aug 26- A new method for removing allergens from peanuts means help could soon be on the way for the roughly 2.8 million Americans with a potentially life-threatening allergy to the popular food, the U.S. Department of Agriculture said on Tuesday.

  • Aug 26- Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck& Co's experimental immunotherapy pembrolizumab, in hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy. The largest U.S. drugmakers said the combination study will begin in 2015 and be conducted by Pfizer.

  • Ebola is 'contained' in Nigeria: Health minister Tuesday, 26 Aug 2014 | 12:05 PM ET
    A pharmacist searches for drugs in a pharmacy in Lagos, Nigeria, July 26, 2014.

    Nigeria's health minister has insisted the Ebola outbreak has been contained in the country.

  • Aug 26- Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck& Co's experimental immunotherapy pembrolizumab, in the hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy. The largest U.S. drugmakers said the combination study will begin in 2015 and be conducted by Pfizer.

  • Ahead of the Bell: Kite Pharma shares jump Tuesday, 26 Aug 2014 | 8:42 AM ET

    Shares of Kite Pharma surged before markets opened Tuesday after the drug developer detailed promising results for its most advanced product, a potential treatment for an aggressive form of non-Hodgkin's lymphoma.

  • Aug 25- Drug developer Kite Pharma Inc said its experimental cancer immunotherapy showed potential in treating patients with an aggressive form of blood cancer, in an early-stage study. In one arm of the study, funded by Kite and conducted by National Cancer Institute, 15 patients were given the therapy.

  • BUZZ-: KITE PHARMA INC: LEAD CANCER DRUG SHOWS PROMISE IN. **Cancer drug developer's shares up 31.2 pct at $29.25 in extended trade. **Says its lead drug has potential to treat aggressive form of blood cancer.